Mohammad Al Hariri

Mohammad Al Hariri


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
MHMarie Ella Horstmann
Marie Ella Horstmann
MHMohammad Al Hariri
Mohammad Al Hariri
SGStephanie Desirée Grabitz
Stephanie Desirée Grabitz
JBJulia Bing Bu
Julia Bing Bu
MAMelissa Apel
Melissa Apel
Joanna Wasielica-PoslednikJoanna Wasielica-Poslednik
Joanna Wasielica-Poslednik
Purpose: (1) To determine the prevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV), and cytomegalovirus (CMV) DNA in donor corneas; (2) To evaluate the clinical outcome of the grafts with viral DNA and to compare donors with and without viral DNA. Methods: We analyzed data from all donors and recipients who underwent penetrating keratoplasty (PK) or Descemet membrane endothelial keratoplasty (DMEK) between September 2022 and March 2023. Donor corneoscleral rims and excised recipients’ corneal buttons were tested for the presence of HSV-1, HSV-2, VZV, and CMV DNA by polymerase chain reaction (PCR). The results were known 2–3 days after the surgery. We closely followed up on patients whose grafts tested positive for viral DNA. We compared the medical histories of donors with and without viral DNA. Results: We included 85 corneas from 67 donors. Seven (8.2%) donor corneas tested positive for HSV-1 (n = 3) or VZV (n = 4) DNA. We did not detect any HSV-2 or CMV DNA. In the postoperative follow-up of patients with positive PCR, a graft failure was observed in one and infections in two eyes. Re-operation was necessary in three of these cases (42.9%). Patients without herpes DNA in the donor cornea needed reoperation in 7.7% of the cases. Cultural duration, the cause of the donor’s death, and the death-to-explantation interval did not differ significantly between donors with and without viral DNA. Additionally, 3 of the 7 (42.9%) donors with positive PCR were in a septic status at the time of death, compared to 21 of the 78 (26.9%) donors with negative PCR (p = 0.52). Conclusions: The prevalence of herpes DNA in the donor corneas was 8.2% and thus higher than previously reported. We did not notice any evidence for a donor-to-host transmission, but a higher rate of postoperative complications in recipients of the grafts with viral DNA. The donors with and without herpetic DNA did not differ significantly regarding systemic diagnoses or cultural conditions, but sepsis was more frequent in the group with viral DNA.

18 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MHMohammad Al Hariri
Mohammad Al Hariri
MMMarkus Munder
Markus Munder
NPNorbert Pfeiffer
Norbert Pfeiffer
Joanna Wasielica-PoslednikJoanna Wasielica-Poslednik
Joanna Wasielica-Poslednik
The purpose of this article is to evaluate the course of paraproteinemic keratopathy (PPK) in patients undergoing systemic therapy for the underlying hematological disease. Baseline and follow-up examinations included hematological work-up, best-corrected visual acuity, slit-lamp biomicroscopy, and in vivo confocal laser scanning microscopy (IVCM). We included 22 patients with bilateral PPK (aged 68 ± 10.4 years, 11 males). Ten patients with multiple myeloma (MM) underwent on-label systemic therapy. During follow-up, we observed a regression of corneal opacities in three patients under slit-lamp examination and under IVCM, while PPK remained unchanged in seven patients. In three patients with monoclonal gammopathy of ocular significance (MGOS), systemic therapy was initiated off-label to reduce the serum paraprotein load before penetrating keratoplasty (PKP). These patients showed no signs of PPK recurrence for up to 24 months after PKP. In one patient without systemic therapy, a recurrence in corneal grafts occurred within 12 months of PKP. In eight patients without systemic therapy, PPK remained stable. In conclusion, systemic therapy for MM patients reduced corneal opacity in 30% of treated patients. Furthermore, systemic therapy performed before PKP in patients without conventional systemic therapy indication (MGOS) likely postpones PPK recurrence in the corneal graft.

8 January 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SGStephanie Desirée Grabitz
Stephanie Desirée Grabitz
AEAnna L. Engel
Anna L. Engel
MHMohammad Al Hariri
Mohammad Al Hariri
Adrian GerickeAdrian Gericke
Adrian Gericke
NPNorbert Pfeiffer
Norbert Pfeiffer
Joanna Wasielica-PoslednikJoanna Wasielica-Poslednik
Joanna Wasielica-Poslednik
Background: Descemet membrane endothelial keratoplasty (DMEK) is the most frequently performed keratoplasty procedure in many countries. One of the most common early complications is an elevation of intraocular pressure (IOP). The aim of this study was to characterize early postoperative IOP behavior following DMEK performed with 10% sulfur hexafluoride (SF6) tamponade and to determine the frequency and timing of required IOP-lowering interventions within the first 48 h. Methods: We retrospectively reviewed postoperative outcomes of 116 consecutive DMEK procedures between May and December 2024 at the University Medical Center in Mainz, Germany. No specific exclusion criteria were applied. All surgeries included a surgical iridectomy at the 6 o’clock position, 10% (SF6) tamponade, and maintaining a mid-normal IOP at the end of surgery. Postoperative assessments included IOP measured using Goldmann applanation tonometry, the percentage of gas fill in the anterior chamber evaluated at the slit lamp, and the need for IOP-lowering interventions as determined by the on-call resident at 3, 24, and 48 h after surgery. IOP-lowering interventions consisted of venting in cases of elevated IOP, gas fill > 90%, and/or suspected angle closure or pupillary block, as well as intravenous or oral acetazolamide in cases of moderate IOP elevation with a lower gas fill and a patent iridectomy. If a single intervention was insufficient, a combined approach was used. Results: A total of 116 eyes from 98 patients (62 female, mean age 73.0 ± 9.8 years) were analyzed. DMEK was combined with cataract surgery in 41 eyes, and 4 eyes underwent phakic DMEK. Postoperatively, all iridectomies remained patent, and no cases of pupillary block occurred. Mean IOP and gas fill were within normal limits and declined steadily during the first 48 h. IOP-lowering procedures were performed in 11 eyes (9.5%), including venting (n = 3), acetazolamide administration (n = 7), and a combination of both (n = 1). There was no difference between DMEK and triple-DMEK regarding postoperative gas fill, IOP, or the need for IOP-lowering interventions. Mean postoperative IOP was significantly higher, and IOP-lowering interventions were more frequent in glaucoma vs. non-glaucoma patients. Re-bubbling was performed in 12 eyes (10.3%). Two cases of primary graft failure (1.7%) were recorded. Conclusions: In our patient cohort, a standardized surgical approach incorporating a surgical iridectomy at the 6 o’clock position, 10% SF6 tamponade, and maintaining a mid-normal IOP at the end of surgery effectively prevented pupillary block. We recommend early postoperative assessment of IOP and percent gas fill to promptly identify and manage impending IOP elevation, which is particularly important in patients with glaucoma.

19 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
SGStephanie Desirée Grabitz
Stephanie Desirée Grabitz
AEAnna Larissa Engel
Anna Larissa Engel
MHMohammad Al Hariri
Mohammad Al Hariri
Adrian GerickeAdrian Gericke
Adrian Gericke
NPNorbert Pfeiffer
Norbert Pfeiffer
Joanna Wasielica-PoslednikJoanna Wasielica-Poslednik
Joanna Wasielica-Poslednik
Background: To assess the need of intraocular pressure (IOP)-lowering procedures following Descemet membrane endothelial keratoplasty (DMEK). Methods: We reviewed postoperative outcomes of consecutive patients, who underwent DMEK between May and December 2024 at the University Medical Center in Mainz, Germany. All surgeries included a surgical iridectomy at the 6 o’clock position, a tamponade with 10% sulfur hexafluoride (SF6) and IOP of about 15 mmHg at the end of surgery. Postoperative outcomes included IOP, per cent gas fill in the anterior chamber, and the need for IOP-lowering interventions, as determined by the on-call resident, at 3-, 24-, and 48-hours post-surgery. Complications, such as re-bubbling and re-keratoplasties, were also collected. Results: A total of 116 eyes from 98 patients (62 female, mean age 73.0±9.8 years) were analysed. DMEK was combined with cataract surgery in 41 eyes, and 4 eyes underwent phakic DMEK. The most common indication for DMEK was Fuchs' endothelial corneal dystrophy in 102 eyes. Postoperatively, all iridectomies remained patent, and no cases of pupillary block occurred. Mean IOP and gas fill at 3, 24, and 48 hours were 16.6±6.8 mmHg / 63±12%; 14.3±4.5 mmHg / 59±15%; and 13.0±3.5 mmHg / 55±15%, respectively. IOP-lowering procedures were performed in 11 eyes (9.5%) included venting (n=3), acetazolamide (n=7), and both (n=1). There was no difference between DMEK and triple-DMEK in terms of postoperative gas fill, IOP, or the need for IOP-lowering interventions. IOP-lowering interventions were more frequent in glaucoma vs. non-glaucoma patients. Conclusions: A standardized surgical approach incorporating a surgical iridectomy at the 6 o’clock position, 10% SF₆ tamponade and maintaining a mid-normal IOP at the end of surgery effectively prevented pupillary block and significant postoperative IOP elevations.